A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study With a Food Effect Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 16 Mar 2016
At a glance
- Drugs TBA 354 (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; First in man
- 11 Mar 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 22 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Feb 2015 This first-in-man trial has been initiated, according to a TB Alliance media release.